Show simple item record

dc.creatorMckeehan, Wallace L.
dc.creatorLuo, Yongde
dc.date.accessioned2019-06-17T16:58:51Z
dc.date.available2019-06-17T16:58:51Z
dc.date.issued2004-11-02
dc.identifier.urihttps://hdl.handle.net/1969.1/176769
dc.description.abstractThe present invention relates to a method and apparatus for isolating anticoagulant heparin or heparan sulfate by binding the anticoagulant heparin or anticoagulant heparan sulfate onto an affinity matrix and separating the non-bound material from the bound material. The affinity matrix is made of a fibroblast growth factor immobilized on a support. The invention also relates to a method and composition for neutralizing anticoagulation catalyzed by heparin, a heparin mimic, or a heparin derivative, by contacting heparin, a heparin mimic, or a heparin derivative with a fibroblast growth factor.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleFGF-affinity chromatographyen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeThe Texas A&M University System
dc.identifier.patentapplicationnumber09/990578
dc.subject.uspcprimary514/56
dc.subject.uspcother514/54
dc.subject.uspcother530/350
dc.subject.uspcother530/413
dc.subject.uspcother536/21
dc.subject.uspcother536/124
dc.subject.uspcother536/127
dc.date.filed2001-11-21
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryC07K 14/50
dc.subject.cpcprimaryA61P 7/02
dc.subject.cpcprimaryA61P 39/00
dc.subject.cpcprimaryC08B 37/0075
dc.subject.cpcprimaryA61K 38/00
dc.subject.cpcprimaryC07K 2319/00


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record